Researchers will evaluate a wide range of outcomes tied to the use of GLP-1. (Valley News Live) – North Dakota State University and Sanford Health are launching a new research collaboration to study how next-generation GLP-1 obesity medications affect patients beyond the number on the scale.
Source: Valley News Live
Indexed: Thu, 25 Jun 2026 18:02:14 UTC
Not a government entity. Not a broker or agent. Public information index only. Verify independently.